Neuralink Begins Patient Recruitment for Groundbreaking Brain Implant Clinical Study

Elon Musk's neurotech startup, Neuralink, has announced that it will be recruiting patients for its first-in-human clinical study, known as the PRIME Study. The study aims to test a cutting-edge brain implant that will enable people with severe paralysis to control external devices through neural impulses. Participants will undergo invasive brain surgery, and the trial is expected to last for six years. This comes after Neuralink received regulatory approval from the FDA, marking a significant milestone in the commercialization of neural interface technology. However, the company still faces criticism for its previous animal experimentation, leading to investigations into animal welfare by government departments. Despite challenges, if proven safe, the brain-computer interface device could pave the way for long-term patient access.